Published in J Struct Biol on July 16, 2009
The Antistaphylococcal Activity of Citropin 1.1 and Temporin A against Planktonic Cells and Biofilms Formed by Isolates from Patients with Atopic Dermatitis: An Assessment of Their Potential to Induce Microbial Resistance Compared to Conventional Antimicrobials. Pharmaceuticals (Basel) (2016) 0.75
Retro analog concept: comparative study on physico-chemical and biological properties of selected antimicrobial peptides. Amino Acids (2017) 0.75
Polyproline II conformation is one of many local conformational states and is not an overall conformation of unfolded peptides and proteins. Proc Natl Acad Sci U S A (2006) 1.57
The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol (2006) 1.10
Rapid screening of antibiotic toxicity in an automated microdroplet system. Lab Chip (2012) 1.09
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 1.06
Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics (2009) 1.04
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation (2003) 1.02
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother (2005) 1.00
Molecular simulation study of cooperativity in hydrophobic association: clusters of four hydrophobic particles. Biophys Chem (2003) 0.99
Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues. J Pept Sci (2006) 0.96
Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother (2002) 0.94
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. Antimicrob Agents Chemother (2007) 0.94
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. J Infect Dis (2005) 0.91
Governing the monomer-dimer ratio of human cystatin c by single amino acid substitution in the hinge region. Acta Biochim Pol (2009) 0.91
Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One (2013) 0.91
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. J Infect Dis (2004) 0.90
Disruption of ionic interactions between the nucleotide binding domain 1 (NBD1) and middle (M) domain in Hsp100 disaggregase unleashes toxic hyperactivity and partial independence from Hsp70. J Biol Chem (2012) 0.90
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides (2008) 0.90
The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides (2003) 0.86
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis (2004) 0.86
Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes. Acta Pol Pharm (2013) 0.85
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. J Antimicrob Chemother (2004) 0.85
Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant. Front Mol Neurosci (2012) 0.84
Conformational stability of the full-atom hexameric model of the ClpB chaperone from Escherichia coli. Biopolymers (2010) 0.84
Deltorphin analogs restricted via a urea bridge: structure and opioid activity. J Pept Sci (2008) 0.83
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg (2002) 0.83
Antimicrobial peptides as potential tool to fight bacterial biofilm. Acta Pol Pharm (2014) 0.82
Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus. Future Med Chem (2012) 0.82
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol (2008) 0.82
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci. Antimicrob Agents Chemother (2007) 0.82
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Int J Antimicrob Agents (2005) 0.82
Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum. J Pept Sci (2013) 0.82
Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia. Chemother Res Pract (2011) 0.82
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides (2007) 0.81
Sorption of ionic liquids onto soils: experimental and chemometric studies. Chemosphere (2012) 0.81
CuII binding sites located at His-96 and His-111 of the human prion protein: thermodynamic and spectroscopic studies on model peptides. Dalton Trans (2008) 0.81
Anticancer effects of CAMEL peptide. Lab Invest (2010) 0.81
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides (2005) 0.81
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Pharmacol Res (2013) 0.81
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci. J Med Microbiol (2011) 0.80
Antitumor activity of antimicrobial peptides against U937 histiocytic cell line. Acta Biochim Pol (2011) 0.80
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock. J Antimicrob Chemother (2002) 0.80
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides (2005) 0.80
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides (2007) 0.80
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. J Antimicrob Chemother (2005) 0.79
Free fatty acids in the cuticular and internal lipids of Calliphora vomitoria and their antimicrobial activity. J Insect Physiol (2013) 0.79
Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J Biol Chem (2013) 0.79
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. J Antimicrob Chemother (2011) 0.79
Effect of cryogrinding on chemical stability of the sparingly water-soluble drug furosemide. Pharm Res (2011) 0.79
The -Cys-Cys- motif in Helicobacter pylori's Hpn and HspA proteins is an essential anchoring site for metal ions. Dalton Trans (2011) 0.79
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. Antimicrob Agents Chemother (2005) 0.78
Antimicrobial and conformational studies of the active and inactive analogues of the protegrin-1 peptide. FEBS J (2010) 0.78
In vitro activity of synthetic antimicrobial peptides against Candida. Pol J Microbiol (2006) 0.78
Synthetic amphibian peptides and short amino-acids derivatives against planktonic cells and mature biofilm of Providencia stuartii clinical strains. Pol J Microbiol (2014) 0.78
The measurement of conformational stability of proteins adsorbed on siloxanes. J Biomater Sci Polym Ed (2003) 0.78
Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. Bioorg Med Chem Lett (2013) 0.78
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats. Crit Care Med (2006) 0.78
Conformational studies of the alpha-helical 28-43 fragment of the B3 domain of the immunoglobulin binding protein G from Streptococcus. Biopolymers (2008) 0.78
Temporin A and its retro-analogues: synthesis, conformational analysis and antimicrobial activities. J Pept Sci (2006) 0.77
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock. Peptides (2003) 0.77
In vitro release of cisplatin from sol-gel processed organically modified silica xerogels. J Mater Sci Mater Med (2007) 0.77
Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5. Inorg Chem (2010) 0.77
Design of protease-resistant pexiganan enhances antileishmanial activity. Parasitol Res (2014) 0.77
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. Mol Biochem Parasitol (2008) 0.77
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. J Antimicrob Chemother (2005) 0.76
The His-His sequence of the antimicrobial peptide demegen P-113 makes it very attractive ligand for Cu2+. J Inorg Biochem (2008) 0.76
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. JPEN J Parenter Enteral Nutr (2007) 0.76
Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part I: Studies in water. J Pept Sci (2008) 0.76
An enormously active and selective azapeptide inhibitor of cathepsin B. J Pept Sci (2007) 0.76
The C terminus of HspA--a potential target for native Ni(II) and Bi(III) anti-ulcer drugs. Dalton Trans (2010) 0.76
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Peptides (2005) 0.76
Utilization of a sol-gel method for encapsulation of doxorubicin. J Biomater Sci Polym Ed (2004) 0.76
Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis. Peptides (2013) 0.76
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. Antimicrob Agents Chemother (2005) 0.76
The antifungal activity of the cuticular and internal fatty acid methyl esters and alcohols in Calliphora vomitoria. Parasitology (2013) 0.76
Activities of synthetic peptides against human pathogenic bacteria. Pol J Microbiol (2004) 0.76
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line. Anticancer Drugs (2005) 0.76
Composition and antimicrobial activity of fatty acids detected in the hygroscopic secretion collected from the secretory setae of larvae of the biting midge Forcipomyia nigra (Diptera: Ceratopogonidae). J Insect Physiol (2012) 0.76